ArticleInternational journal of sports physical therapy2026
Defining the Minimal Clinically Important Difference (MCID), Patient Acceptable Symptom State (PASS), and Maximal Outcome Improvement (MOI) values for individuals with acetabular dysplasia (AD) undergoing non-operative management.
Article in International journal of sports physical therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The International Hip Outcome Tool 12 (iHOT-12) is commonly utilized to track outcomes in individuals with acetabular dysplasia (AD). Clinically important outcome values (CIOVs) of the iHOT-12 in individuals with AD are not yet defined. Purpose: To define the minimal clinically important difference (MCID), patient acceptable symptom state (PASS) change score, absolute PASS threshold, and maximal outcome improvement (MOI) value for the iHOT-12 in individuals undergoing physiotherapy (PT) for AD. Study Design: Prospective cohort; psychometric property analysis. Methods: This prospective study included individuals aged 10-35 years with a clinical and radiographic diagnosis of AD who were referred for conservative management at two centers between December 2023 and February 2025. At baseline assessment and after 8-10 weeks of PT, individuals completed the iHOT-12. At 8-10-week follow-up, individuals also completed three anchor questions on satisfaction and function. The MCID was calculated utilizing 0.5 times the standard deviation of baseline iHOT-12 scores. Receiver operator curve analysis was utilized to determine the PASS change score, absolute PASS threshold, and MOI value. Results: Forty-five patients (42 females, mean age 16.5 + 7.8) met the inclusion criteria. After 8-10 weeks of PT (mean follow-up time = 69 days), 25 (55.6%) participants were in the "improved" group and 20 (44.4%) were in the "not improved" group. The MCID was 8.5 points. A PASS change score of 15.2 was calculated for individuals who were satisfied with high sensitivity (.77) and specificity (.78) with an AUC = .76 (95% CI: .59-.93). An absolute PASS iHOT-12 threshold score of 62 (sensitivity = .62, specificity = .87) identified those who were satisfied with their hip function after a trial of PT with an AUC = .82 (95% CI: .67-.97). An MOI threshold of 22.9% was also calculated with high sensitivity (.69) and specificity (.88) with an AUC = .78 (95% CI: .61-.95). Conclusion: This study defines MCID, PASS change score, absolute PASS threshold, and MOI threshold for the iHOT-12 in patients with AD after 8-10 weeks of PT. While most individuals reported improvement in symptoms, only half of individuals were satisfied with their current level of function. Level of Evidence: Level 2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.